Drugs / 68Ga-A3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06194630 | Nov → Dec 2023 | lung cancer | Peking Union Medical College Hospital | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 68Ga-A3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06194630 ↗ |
| Modality | Diagnostic / imaging agent | “ACE2-targeting PET agents” NCT06194630 ↗ |
| Route | Intravenous | “Intravenous injection of 68Ga-A3” NCT06194630 ↗ |
| Target | ACE2 | “ACE2-targeting PET agents” NCT06194630 ↗ |